Panacea Life Sciences Holdings, Inc.: 10-Q filed 2017-11-20

Name: Panacea Life Sciences Holdings, Inc.: 10-Q filed 2017-11-20
Creator: Panacea Life Sciences Holdings, Inc.

What Panacea Life Sciences Holdings, Inc. reported in its quarterly report filed 2017-11-20 (fiscal Q3 2017): 27 published measures, 75 facts as tagged in accession 0001654954-17-010893.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-20
Fiscal period: fiscal Q3 2017
Accession: 0001654954-17-010893 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Panacea Life Sciences Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	1,053,151	USD
At 2016-12-31	2,125,057	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-09-30	1,353,246	USD
At 2016-12-31	624,974	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	-300,095	USD
At 2016-12-31	1,500,083	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	32,968	USD
At 2016-12-31	1,055,336	USD
At 2016-09-30	34,494	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-717,819	USD	92
2017-01-01 to 2017-09-30	-1,825,128	USD	273
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-855,507	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-1,204,118	USD	273
2016-01-01 to 2016-09-30	-484,140	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2017-07-01 to 2017-09-30	USD	92
2017-01-01 to 2017-09-30	USD	273
2016-07-01 to 2016-09-30	USD	92
2016-01-01 to 2016-09-30	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	181,750	USD	273
2016-01-01 to 2016-09-30	445,000	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	0	USD	273
2016-01-01 to 2016-09-30	1,292	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-4,165,026	USD
At 2016-12-31	-2,339,898	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-490,207	USD	92
2017-01-01 to 2017-09-30	-1,597,516	USD	273
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-854,054	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	1,053,151	USD
At 2016-12-31	2,075,057	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	17,362	USD	92
2017-01-01 to 2017-09-30	17,362	USD	273
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	0	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	1,353,246	USD
At 2016-12-31	624,974	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	645,566	USD
At 2016-12-31	566,495	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	490,207	USD	92
2017-01-01 to 2017-09-30	1,597,516	USD	273
2016-07-01 to 2016-09-30	359,813	USD	92
2016-01-01 to 2016-09-30	854,054	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	87,000	USD	92
2017-01-01 to 2017-09-30	281,076	USD	273
2016-07-01 to 2016-09-30	97,244	USD	92
2016-01-01 to 2016-09-30	216,644	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	33,571,862	shares
At 2016-12-31	34,071,862	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	3,860,253	USD
At 2016-12-31	3,835,263	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-09-30	323,858	USD
At 2016-12-31	58,479	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-717,819	USD	92
2017-01-01 to 2017-09-30	-1,825,128	USD	273
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-855,507	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	293,540	USD	92
2017-01-01 to 2017-09-30	900,478	USD	273
2016-07-01 to 2016-09-30	142,573	USD	92
2016-01-01 to 2016-09-30	378,650	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-227,612	USD	92
2017-01-01 to 2017-09-30	-227,612	USD	273
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	-1,453	USD	274

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Unit	Days
2017-07-01 to 2017-09-30	USD	92
2017-01-01 to 2017-09-30	USD	273
2016-07-01 to 2016-09-30	USD	92
2016-01-01 to 2016-09-30	USD	274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	0	USD	273
2016-01-01 to 2016-09-30	0	USD	274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	0	USD	273
2016-01-01 to 2016-09-30	0	USD	274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	79,071	USD	273
2016-01-01 to 2016-09-30	330,392	USD	274

Inspect the source

Entity: Panacea Life Sciences Holdings, Inc. / CIK 0001552189
Captured: 2026-09-20T09:18:48.131Z
SEC response SHA-256: ab0fb9e968655e139f69554f75636a16ed20b7f4fdbb18db5bb98dd1523ff07d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001552189.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))